1. Pink Sheet
  2. >>Pathways & Standards
  3. >>User Fees

BsUFA III Expands Biosimilar Supplement Review Goals To Speed Approvals

 
• By Derrick Gingery

Six supplement categories based on submission content will be created with review goals between three and 10 months.

FDAEntrance_1200x675
The FDA plans to hire an additional 15 employees to help implement the BsUFA III program changes.

The biosimilar supplement review system in the US will undergo a substantial expansion during the upcoming user fee cycle as part of an effort to streamline the process and create more certainty for sponsors.

Some supplements could receive as short as a three-month assessment under the new goals and categories in the BsUFA III commitment letter released on 21 September, which outlines program changes negotiated by industry and US Food and Drug Administration representatives

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from User Fees

More from Pathways & Standards

US FDA Vaccine Framework Coming In Weeks, But Details Vague

 
• By Sarah Karlin-Smith

New CBER Director Prasad will "unleash a massive" framework on vaccines, FDA Commissioner Marty Makary said 15 May, raising questions about the impact on products nearing approval.

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada

 
• By Eliza Slawther

Companies that use the European Medicines Agency as a reference regulator for the UK’s International Recognition Procedure can expect a faster approval than those that use other national regulators, such as those in the US and Canada, an MHRA spokesperson has said.

HHS Secretary Kennedy Says Trump Will Make Final Decision On Mifepristone Policy

 
• By Derrick Gingery

With an FDA review ongoing, Kennedy’s admission, made during a Senate hearing on the Health and Human Services Department’s budget request, suggests political officials could supersede scientific decisions.